socalTECH

NOVEMBER 18, 2014

San Diego-based Renova Therapeutics , a biopharmaceuticals company developing treatments for congestive heart failure and other diseases, has raised $7.52M in a Series C funding round. Bradbury has joined the company''s board. The company said the funding primarily came from high net worth individuals.

Bradbury 138

Bradbury San Diego .Net Venture Capital 138

socalTECH

NOVEMBER 27, 2017

San Diego-based Biolinq , a startup developing wireless-enabled, biosensor patches aimed at continually monitoring blood glucose levels, has raised $10M in a Series A funding, the company said this morning. Biolinq is led by CEO Jared Tangney.

Bradbury 113

Bradbury San Diego Funding Startup 113

socalTECH

MAY 13, 2014

San Diego-based Liquid Grids , a developer of digital advertising software aimed at the healthcare industry, said this morning that it has raised a Series A funding round. Bradbury, former CEO of Amylin Pharmacueticals, as a new Chairman of its board, and also added Sherman Atkinson as a Director of the company with the funding.

Bradbury 100

Bradbury Marketing Miramar Advertising 100

Xconomy

FEBRUARY 28, 2019

Headed by former Amylin CEO Dan Bradbury, Equillium (NASDAQ: EQ ) has licensed the drug, itolizumab, which it calls EQ001, from Indian pharma giant Biocon Limited for development in the United States and Canada. Equillium was formed to advance.

Bradbury 85

Bradbury Develop Development Company 85